申请人:Chen Li
公开号:US20080146559A1
公开(公告)日:2008-06-19
The present invention relates to compounds of formula I
wherein R
1
and R
2
are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
本发明涉及式I的化合物,其中R1和R2如描述和权利要求中定义,并且其药用盐。这些化合物可用于治疗和/或预防与H3受体调节相关的疾病。